Founded with a mission to revolutionize patient care, SweetBio is a medical device company that specializes in bioengineered, honey-incorporated wound care products. Their core vision is to simplify the healing journey for patients suffering from non-healing wounds. SweetBio offers innovative products such as VERIS™ and APIS® wound dressings, which combine collagen and Manuka honey to provide effective and easy-to-use solutions. The company's market focus is on providing advanced wound care solutions that improve patient outcomes.
Notable affiliated people and investors include key figures in the medical and biotech industries who have recognized the potential of SweetBio's technology. Since its inception, SweetBio has achieved significant milestones, including FDA clearance for their products in May 2019. The company has made a substantial impact by offering a novel approach to wound care, leveraging the natural healing properties of Manuka honey to enhance patient comfort and accelerate recovery.
